Discover everything you need to know about Irritable Bowel Syndrome (IBS) and the limitations of its current treatments through our reference list.
Approximately 30% of individuals with IBS have severe symptoms.
Women are twice as likely to be affected by IBS compared to men.
IBS results in a significant economic burden due to healthcare costs and lost productivity.
IBS negatively affects the quality of life for approximately 40% of sufferers.
About 50-90% of individuals with IBS also experience anxiety or depression.
IBS contributes to millions of visits to healthcare providers annually worldwide.
Approximately 1 in 7 Australians are affected by IBS.
IBS costs the Australian healthcare system approximately $1.5 billion annually.
Less than 20% of patients with IBS were satisfied with over the counter treatments.
63% were not satisfied with prescription treatment.